-
GSK Announces Commitment to Improving Access to Vaccines With 5-year Price Freeze
GlaxoSmithKline (GSK) has announced that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support. By committing to offer GAVI Alliance prices for vaccines against pneumonia, diarrhoea and cervical cancer, GSK will support developing country governments as they transition to financing the full cost of their local vaccination programmes.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
How to Prevent the Next Health Crisis: Without vaccines, we’re vulnerable not just to Ebola, but a variety of other deadly diseases
More than 20 million kids weren’t vaccinated last year. How do we fix that problem? Dr. Utibe Effiong says we can start by engaging with more religious leaders to encourage vaccination. More importantly, we must invest in job creation to bring families out of poverty. When a family is hungry, vaccination is their last priority.
- Categories
- Health Care
-
Global Health Investment Fund Leads Investment into Low-Cost Oral Cholera Vaccine for the World’s Poor
South Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers.
- Categories
- Health Care
-
Male Rickshaw Drivers Playing Key Role In Maternal Health Campaign In India
As the autorickshaws begin lining up inside the compound at 7 a.m., Vijaylakmi Sahu knows she has just 30 minutes to finish her work. Over the next half hour, Sahu works with clockwork precision. She ensures that the temperatures of the vaccines for pregnant women and children are checked before they are packed under her supervision in cold boxes. After that, three to five autorickshaws, known as the Immunization Express, head off to the villages where mothers, children and pregnant women await them.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
The Economic Case for Wiping Out Ebola
On Aug. 22, the World Health Organization announced a draft strategy to combat the West African Ebola outbreak over the next six to nine months. That’s a sign that the global health body isn’t optimistic about a rapid end to an epidemic that has killed around 1,300 people so far. An extended outbreak of such a feared disease would have mounting economic costs.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Glimmer of hope seen in Ebola outbreak
Three health care workers who were given the experimental Ebola drug ZMapp in Liberia have shown "very positive signs of recovery," the Liberian Ministry of Health said Tuesday. Medical professionals treating the workers have called their progress "remarkable."
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Humans give malaria to mosquitoes – we need a vaccine to stop this
On Wednesday, the world marks World Mosquito Day to commemorate the 1897 discovery by British doctor Sir Ronald Ross that malaria in people is transmitted to and from mosquitoes. Ross won a Nobel prize for his discovery, and, since then, mosquitoes have been enemy No 1 when it comes to defeating a disease that takes a life every single minute – most of them children in sub-Saharan Africa. But on this day, let’s focus on approaching malaria in a surprising new way: a vaccine to stop humans from giving malaria to mosquitoes.
- Categories
- Education, Health Care
- Tags
- product design, research, vaccines
-
Dengue vaccine is just a year away, researchers say
A new vaccine that can halve the number of dengue cases provides a welcome shot to fight a deadly disease that infects around 390 million people every year in the tropics.
- Categories
- Education, Health Care
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.